Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin – a retrospective analysis of medical charts and re-imbursement data of real-life patient populations

Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin – a retrospective analysis of medical charts and re-imbursement data of real-life patient populations

Objectives: To supplement the data collected in randomized clinical trials, the present study in patients with methicillin resistant (MRSA) pneumonia was conducted to explore the clinical effectiveness of linezolid and vancomycin in a routine clinical setting. Further, the overall costs of the pati...

Full description

Bibliographic Details
Main Authors: Wilke, Michael H., Becker, Karsten, Kloss, Sebastian, Heimann, Sebastian M., Goldmann, Anton, Weber, Bertram, Pletz, Mathias W., Simon, Philipp, Petrik, Christian
Format: Article
Language:English
Published: German Medical Science GMS Publishing House 2017-01-01
Series:GMS Infectious Diseases
Subjects:
linezolid
vancomycin
methicillin resistant Staphylococcus aureus
pneumonia
treatment outcome
cost-benefit analysis
Zyvox®, Pfizer
Online Access:http://www.egms.de/static/en/journals/id/2017-5/id000028.shtml

Internet

http://www.egms.de/static/en/journals/id/2017-5/id000028.shtml

Similar Items